Get Healthy!
Results for search "Cancer: Lymphoma".
Health News Results - 29
.jpg?w=1920&h=1080&mode=crop&crop=focalpoint)
People who have a condition putting them at high risk for a bone marrow cancer may be able to ward off the malignancy with a high-fiber diet, new research shows.
The study focuses on patients with what's known as monoclonal gammopathy of undetermined significance (MGUS). It's a bone marrow abnormality that's often a precursor to multiple myeloma, one of the most common forms of blood...
- Ernie Mundell HealthDay Reporter
- |
- December 9, 2024
- |
- Full Page
Jenna Cottrell is a young sports reporter working for a TV station in the Rochester, N.Y., area.
She's also a survivor of advanced Hodgkin lymphoma, who first got diagnosed at the age of 25 back in 2017.
After 12 rounds of the then standard-of-care treatment chemotherapy, "I've been in remission since 2017," Cottrell said in an interview at the University of Rochester Medical Cente...
- Ernie Mundell HealthDay Reporter
- |
- October 16, 2024
- |
- Full Page
Patients with a fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, the largest study examining its use in a community setting has found.
CAR-T is shorthand for chimeric antigen receptor therapy. In this treatment, doctors remove the patient's own white blood cells, tweak them in a lab and then infuse them back into the patient to attack and kill ca...
- Carole Tanzer Miller HealthDay Reporter
- |
- October 1, 2024
- |
- Full Page
Blood cancer patients of all races who receive cord blood transplants are now living longer.
The finding, reported by a team led by oncologist Dr. Karen Ballen, of UVA (University of Virginia) Health, shows that a previously identified survival gap for transplant recipients has been eliminated.
"Outcomes for cor...
- Carole Tanzer Miller HealthDay Reporter
- |
- October 1, 2024
- |
- Full Page
Blood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best to catch them early is essential, one expert says.
First, blood cancers are far more common than you might think: One person in the United States is diagnosed with a
An experimental cancer treatment regimen is achieving full remissions in some patients with aggressive B-cell lymphoma, researchers report.
The five-drug combination does not include chemotherapy. Rather, it simultaneously zeroes in on several molecular pathways that diffuse large B-cell lymphoma (DLBCL) tumors rely on to survive. B-cell lymphoma is a cancer of cells in the body's i...
- Carole Tanzer Miller HealthDay Reporter
- |
- June 21, 2024
- |
- Full Page
Research suggests that tattoo ink spurs inflammatory changes that might contribute to the development of lymphoma.
The findings are early, however, and more study must be done to confirm any links between tattooing and the blood cancer, Swedish researchers stressed.
"People will likely want to continue to express their identity through tattoos, and therefore it is very important tha...
- Ernie Mundell HealthDay Reporter
- |
- May 29, 2024
- |
- Full Page
An older drug used in a new way could open the path for more patients with potentially deadly blood cancers to receive a lifesaving stem cell transplant, a new study finds.
The drug, cyclophosphamide, could help patients receive a stem cell transplant even if the donor isn't a relative and only partially matches their blood type, researchers report.
Blood cancer patients had a high ...
- Dennis Thompson HealthDay Reporter
- |
- May 28, 2024
- |
- Full Page
Polycythemia vera is a rare form of blood cancer with few good treatment options, but that may soon change based on the results of a new clinical trial.
An injected experimental drug called rusfertide appears effective in reducing the excess production of red blood cells that's a hallmark of the disease.
"Rusfertide appears to represent a significant step forward in treating polycyt...
- Ernie Mundell HealthDay Reporter
- |
- February 26, 2024
- |
- Full Page
CT scans are significantly linked to an increased risk of blood cancers in young people, a major multinational study has found.
Analysis of data from nearly 1 million people under 22 who underwent at least one CT scan found a strong and clear link between exposure to the scans' radiation and blood cancers, according to findings published Nov. 9 in the journal
Weight-loss surgery can deliver a host of health benefits, but new research reveals an unexpected one: Getting the surgery was associated with a 40% lower risk of blood cancers.
Being overweight or obese is a risk factor for several types of cancer, and women with obesity have a higher risk of cancer than men do.
In the study, researchers used data from the Swedish Obese Subjects (...
- Cara Murez HealthDay Reporter
- |
- September 25, 2023
- |
- Full Page
Research into a possible link between childhood health problems and natural gas wells in western Pennsylvania is wrapping up with some answers.
Children who lived near these wells were more likely to develop rare lymphoma, the research found.
In addition, residents of all ages near the wells had increased risk of severe asthma reactions, the Associated Press reported.
- Cara Murez HealthDay Reporter
- |
- August 16, 2023
- |
- Full Page
Radiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment, a pair of new clinical trials shows.
One trial found that rectal cancer patients whose tumors shrink in response to chemotherapy can safely skip the radiation therapy that's normally provided prior to surgery, researchers reported at the American Societ...
- Dennis Thompson HealthDay Reporter
- |
- June 6, 2023
- |
- Full Page
The widely used immunotherapy drug nivolumab (Opdivo) is safer and more effective in treating adults and children with advanced Hodgkin lymphoma than the targeted therapy now used as standard care is, new clinical trial results show.
Nivolumab outperformed the drug brentuximab vedotin (Adcetris), extending progression-free survival by 94% at one year compared to 86%, said lead researcher ...
- Dennis Thompson HealthDay Reporter
- |
- June 6, 2023
- |
- Full Page
Not a lot is known about how physicians should handle cases in which a pregnant woman is diagnosed with relapsed/refractory lymphoma.
A new study may provide some perspective.
Though uncommon, this issue is still experienced by about one in 4,000 women, according to background notes with the study published June 1 in
A therapy that bolsters the immune system may not only help certain cancer patients live longer, but better, a new study finds.
The treatment, called chimeric antigen receptor (CAR) T-cell therapy, is used to fight certain types of blood cancer -- including leukemia and lymphoma -- that have not responded to standard treatments.
It involves removing a patient's own immune system T-c...
- Amy Norton HealthDay Reporter
- |
- April 5, 2023
- |
- Full Page
Actress and two-time Academy Award winner Jane Fonda announced Thursday that her non-Hodgkin lymphoma is in remission.
Fonda, 84, said in a blog post that she can quit chemotherapy treatments, calling it the "BEST BIRTHDAY PRESENT EVER!!!" Fonda, also a climate activist, will turn 85 on Wednesday.<...
- Cara Murez HealthDay Reporter
- |
- December 16, 2022
- |
- Full Page
If someone is stricken with a blood cancer or life-threatening clot, they'll probably fare better if they are white and wealthy, three new studies show.
The ongoing impact of patient race and income to medical outcomes was in the spotlight Saturday in New Orleans at the annual meeting of the American Society of Hematology (ASH).
In one study, a team led by
The breast cancer of author and poet Stephanie Gangi has receded and advanced in wearying waves for two decades now.
First diagnosed and treated in 1999, Gangi's cancer spread to the bone of her sternum in 2014. In 2021, a tumor the size of an orange appeared on her adrenal gland.
"I could not possibly tell you the number of treatments I've been through,"said Gangi, 66, of New York ...
- Dennis Thompson HealthDay Reporter
- |
- November 11, 2022
- |
- Full Page
The U.S. Food and Drug Administration on Thursday warned doctors and their patients about rare cases of squamous cell carcinoma and various lymphomas developing in the scar tissue that forms around breast implants.
- By Cara Murez HealthDay Reporter
- |
- September 9, 2022
- |
- Full Page
Actress Jane Fonda has announced she has non-Hodgkin lymphoma.
Fonda, 84, said she has started chemotherapy to fight the highly treatable cancer, calling herself very lucky because 80% of patients survive.
Also known for her social activism, Fonda noted she has health insurance and access to the best doc...
- By Cara Murez HealthDay Reporter
- |
- September 6, 2022
- |
- Full Page
In a promising development, new research has discovered that most adults with blood cancers develop at least some immunity to COVID-19 after getting booster shots.
"Our findings build on the wealth of literature showing that patients with
More than 10 years after Doug Olsen underwent an experimental gene therapy that turned his T-cells into cancer killers, his leukemia has vanished, University of Pennsylvania doctors report.
"I'm doing great right now. I'm still very active. I wa...
- Robin Foster and Robert Preidt
- |
- February 2, 2022
- |
- Full Page
Many insured cancer patients still experience serious money problems linked to their illness, new research affirms.
For example, nearly 3 out of 4 insured patients with colon cancer have major financial hardship in the year after their diagnosis, which affects their social functioning and quality of life, according to
Anti-vaxxers felt their suspicions confirmed when former U.S. Secretary of State Colin Powell died from COVID-19 complications in mid-October despite being fully vaccinated.
But Powell, 84, was being treated for blood cancer at the time of his death, and a new study reports that the COVID vaccines are producing little to no protection for some cancer patients.
Nearly 3 out of 5 bloo...
- Dennis Thompson HealthDay Reporter
- |
- October 27, 2021
- |
- Full Page
Private insurers paid out about $156.2 billion in 2018 for U.S. patients with the 15 most common cancers.
Medication was the largest expense and drugs for breast, lung, lymphoma and colon cancers accounted for the largest chunk of those costs, according to a Penn State College of Medicine study.
"The public often hears that the U.S. spends an inordinate amount of money on health car...
- Robert Preidt
- |
- October 13, 2021
- |
- Full Page
Jeff Bridges has had a rough year.
Almost a year ago, the actor was diagnosed with lymphoma. Then in January, he was exposed to the COVID-19 virus while receiving chemotherapy.
"Covid kicked my (expletive) pretty good," Bridges wrote in a blog post on his website, USA Today reported.
Bridges, 71, said he spent five weeks in the hospital with COVID-19 because his immun...
- Cara Murez
- |
- September 15, 2021
- |
- Full Page
Patients with B-cell blood cancers who did not make antibodies to COVID-19 after two shots of vaccine may find that a third shot does the trick, new research finds.
More than half the patients who had failed to respond to the first two shots had a positive response to the third, or booster, shot, according to the Leukemia & Lymphoma Society study.
"The additional COVID-19 vaccine do...
- Steven Reinberg
- |
- September 15, 2021
- |
- Full Page